Clinical Trial Update: Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating buprenorphine for incomplete response in late-life depression; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Jordan F. Karp | Conditions: Depression, Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-07-02